Difference between revisions of "Part:BBa K1124011"
Minakuchi.T (Talk | contribs) |
|||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K1124011 short</partinfo> | <partinfo>BBa_K1124011 short</partinfo> | ||
− | + | ===Usage and Biology=== | |
+ | This part consists of ''hpaB'' and ''hpaC'' genes, and is called ''hpaBC'' | ||
+ | The products of these genes, HpaB and HpaC, together form an enzyme 4-hydroxyphenylacetate 3-hydroxylase. This enzyme hydroxylates L-tyrosine to produce L-DOPA ''in vivo''. | ||
− | + | It is known that hpaBC overexpression leads to increase of L-DOPA production in E. coli. | |
− | + | We designed L-DOPA sythesis device([[Part:BBa_K1124107]]) by combining this part and tyrosine synthesis device([[Part:BBa_K1124106]]). | |
− | |||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_K1124011 SequenceAndFeatures</partinfo> | <partinfo>BBa_K1124011 SequenceAndFeatures</partinfo> |
Revision as of 22:43, 27 September 2013
hpaBC (+RBS(natural))
Usage and Biology
This part consists of hpaB and hpaC genes, and is called hpaBC The products of these genes, HpaB and HpaC, together form an enzyme 4-hydroxyphenylacetate 3-hydroxylase. This enzyme hydroxylates L-tyrosine to produce L-DOPA in vivo.
It is known that hpaBC overexpression leads to increase of L-DOPA production in E. coli. We designed L-DOPA sythesis device(Part:BBa_K1124107) by combining this part and tyrosine synthesis device(Part:BBa_K1124106).
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 97
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 1877